Opinion - Letters to the Editor   

Unhealthy practice

Pharmaceutical companies spend a whopping $19 billion annually for establishing and maintaining a relationship with doctors to increase the sale of their drugs as mentioned in the editorial “Towards greater transparency” (Nov. 5). Competition among drug firms is welcome if it can facilitate the production of quality drugs and their sale at comparatively low prices. But it is not a good trend if the rates of drugs are pitched high and the companies try to push them into the market by influencing or goading the medical practitioners to prescribe those expensive medicines to their patients.

R.M. Manoharan,

Chennai

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

An alternative source of funds
A clean-up in the UAE
The sting in its social and ethical context
Torture and ‘humanitarian war’
Gloomy days for American influence
Clots are a hazard of long business flights
North biofuel appetite causing South starvation
Corrections and clarifications
Situation in Pakistan
Right time
Violence in Sri Lanka
Recovery agents
Unhealthy practice

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu